Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-24

FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)

View source ↗

Summary

FDA approved a supplemental application for Enalapril Maleate by Oceanside Pharmaceuticals under NDA 018998. The approval updates the product via a supplemental…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalapril maleate (enalapril maleate)

Snippet

SUPPL AP for ENALAPRIL MALEATE (ENALAPRIL MALEATE)